Please assess the completion status of the following clinical trial:

Trial Title: Effect of Saccharomyces Cerevisiae on Improving the Effectiveness of Conventional Treatment of Vulvo-vaginal Candidiasis

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: SUPPORTIVE_CARE
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Premenopausal female patient with a clinical diagnosed vulvo-vaginal candidiasis~* Regularly menstruating women with normal gynaecological status~* Patient must use a contraception method~* Having given a written informed consent prior to selection~* Covered by Health Insurance System and / or in compliance with the recommendations of National Law in force relating to biomedical research.~Exclusion Criteria:~* Pregnancy or breast feeding.~* Tumors in the genital tract or beast.~* Hypersensitivity to the study product.~* Uterine or vaginal bleeding of unknown origin.~* Use of systemic or intravaginal antibiotic or antifungal agents in the previous 14 days.~* Concomitant medication with antimycotics for other diagnoses.~* Woman with known transmitted infections such as Neisseria gonorrhoea, Chlamydia trachomatis, Treponema pallidum, herpes simplex, Trichomonas vaginalis, human papilloma virus, HIV 1 or 2.~* Immunocompromised individuals.~* Subjects not willing to stop taking probiotics in the form of dietary supplements or convenient goods~* Subject who, in the judgment of the Investigator, is likely to be non-compliant or uncooperative during the study, or unable to cooperate because of a language problem, poor mental development.~* Subject under administrative or legal supervision.~* Subject who participate to a previous study within 3 months.

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Saccharomyces cerevisiae CNCM I-3856 (Type: ACTIVE_COMPARATOR): In this arm, subjects will be asked to consume one capsule of Saccharomyces cerevisiae CNCM I-3856 per day.
- placebo (Type: PLACEBO_COMPARATOR): In this arm, subjects will be asked to consume one capsule of placebo per day.

Based on this trial design, predict the completion outcome and termination type (if applicable).